Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the U.S.

The Food and Drug Administration recently approved a blood test called Shield by the company Guardant Health. The test looks for fragments of DNA shed from colon cancers and polyps. If it finds ...

it is critical to develop and implement initiatives to improve screening for all," she said. More information: Find out more about colonoscopy prep at the Cleveland Clinic.

Before CMS’s statement about Medicare PrEP coverage earlier this week, Medicare covered PrEP for over 45,000 clients through its Part D program, which covers prescription drugs, according to HIV+Hep.

Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, freeing the company from competing with compounding pharmacies that have ...

The Purpose I study, sponsored by the drug manufacturer Gilead Sciences, included 5,000 women aged 16 and 25 years in Uganda and South Africa, and tested lenacapavir against two other PrEP drugs ...

The Centers for Medicare & Medicaid Services (CMS) rolled out guidance Oct. 2 as stakeholders prep for the second round of the drug price negotiation program. Made possible through the Inflation ...

Oral PrEP drugs had been paid for under Medicare's Part D drug program, but Part D doesn't normally cover physician-administered drugs. And although some Part D plans had been paying for the long ...